Literature DB >> 21684202

Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.

Christian Renaud1, Jane Kuypers, Janet A Englund.   

Abstract

The emergence of oseltamivir resistance in seasonal and pandemic influenza A/H1N1 has created challenges for diagnosis and clinical management. This review discusses how clinical virology laboratories have handled diagnosis of oseltamivir-resistant H1N1 and what we have learned from clinical studies and case series. Immunocompetent patients infected with oseltamivir-resistant H1N1 have similar outcomes as patients infected with oseltamivir-susceptible H1N1. However, immunocompromised patients infected with oseltamivir-resistant H1N1 experience potentially more risks of complication and transmissibility with few therapeutic options.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21684202     DOI: 10.1016/j.jcv.2011.05.019

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  21 in total

1.  An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.

Authors:  Yanmei Hu; Rami Musharrafieh; Chunlong Ma; Jiantao Zhang; Donald F Smee; William F DeGrado; Jun Wang
Journal:  Antiviral Res       Date:  2017-01-10       Impact factor: 5.970

2.  The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.

Authors:  Lady Tatiana Pinilla; Benjamin P Holder; Yacine Abed; Guy Boivin; Catherine A A Beauchemin
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

3.  Discovery of cyclosporine A and its analogs as broad-spectrum anti-influenza drugs with a high in vitro genetic barrier of drug resistance.

Authors:  Chunlong Ma; Fang Li; Rami Ghassan Musharrafieh; Jun Wang
Journal:  Antiviral Res       Date:  2016-07-28       Impact factor: 5.970

Review 4.  Within-Host Evolution of Human Influenza Virus.

Authors:  Katherine S Xue; Louise H Moncla; Trevor Bedford; Jesse D Bloom
Journal:  Trends Microbiol       Date:  2018-03-10       Impact factor: 17.079

5.  Systematic identification of H274Y compensatory mutations in influenza A virus neuraminidase by high-throughput screening.

Authors:  Nicholas C Wu; Arthur P Young; Sugandha Dandekar; Hemani Wijersuriya; Laith Q Al-Mawsawi; Ting-Ting Wu; Ren Sun
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

6.  Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil.

Authors:  Camila Marx; Tatiana Schäffer Gregianini; Fernanda Kieling Moreira Lehmann; Vagner Ricardo Lunge; Silvia de Carli; Bibiana Paula Dambrós; Gabriela Luchiari Tumioto; Claudete Seadi; André Salvador Kazantzi Fonseca; Nilo Ikuta
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

7.  Prevention of infection caused by immunosuppressive drugs in gastroenterology.

Authors:  Katarzyna Orlicka; Eleanor Barnes; Emma L Culver
Journal:  Ther Adv Chronic Dis       Date:  2013-07       Impact factor: 5.091

Review 8.  Continuing challenges in influenza.

Authors:  Robert G Webster; Elena A Govorkova
Journal:  Ann N Y Acad Sci       Date:  2014-05-30       Impact factor: 5.691

9.  Using high-throughput sequencing to leverage surveillance of genetic diversity and oseltamivir resistance: a pilot study during the 2009 influenza A(H1N1) pandemic.

Authors:  Juan Téllez-Sosa; Mario Henry Rodríguez; Rosa E Gómez-Barreto; Humberto Valdovinos-Torres; Ana Cecilia Hidalgo; Pablo Cruz-Hervert; René Santos Luna; Erik Carrillo-Valenzo; Celso Ramos; Lourdes García-García; Jesús Martínez-Barnetche
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

10.  Molecular distribution of amino acid substitutions on neuraminidase from the 2009 (H1N1) human influenza pandemic virus.

Authors:  Miguelmiguel Quiliano; Hugo Valdivia-Olarte; Carlos Olivares; David Requena; Andrés H Gutiérrez; Paola Reyes-Loyola; Luis E Tolentino-Lopez; Patricia Sheen; Verónica Briz; Maria A Muñoz-Fernández; José Correa-Basurto; Mirko Zimic
Journal:  Bioinformation       Date:  2013-07-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.